User profiles for Otto O. Yang
 | Otto YangProfessor, University of California Los Angeles Verified email at mednet.ucla.edu Cited by 13084 |
[HTML][HTML] Rapid decay of anti–SARS-CoV-2 antibodies in persons with mild Covid-19
Covid-19 Antibodies after Mild Infection Among 34 volunteers who had recovered from mild
Covid-19 illness, antiviral antibodies to the receptor-binding domain of the viral spike protein …
Covid-19 illness, antiviral antibodies to the receptor-binding domain of the viral spike protein …
Hydrodynamic stretching of single cells for large population mechanical phenotyping
…, Y Ying, AG Lindgren, OO Yang… - Proceedings of the …, 2012 - National Acad Sciences
Cell state is often assayed through measurement of biochemical and biophysical markers.
Although biochemical markers have been widely used, intrinsic biophysical markers, such as …
Although biochemical markers have been widely used, intrinsic biophysical markers, such as …
[HTML][HTML] Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo …
…, JT Baron, N Ahuja, E Ling, M Go, OO Yang… - The lancet respiratory …, 2021 - thelancet.com
Background Functional impairment of interferon, a natural antiviral component of the
immune system, is associated with the pathogenesis and severity of COVID-19. We aimed to …
immune system, is associated with the pathogenesis and severity of COVID-19. We aimed to …
Retrocyclin: a primate peptide that protects cells from infection by T-and M-tropic strains of HIV-1
Human bone marrow expresses a pseudogene that encodes an antimicrobial peptide
homologous to rhesus monkey circular minidefensins (θ-defensins). We prepared the putative …
homologous to rhesus monkey circular minidefensins (θ-defensins). We prepared the putative …
Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms
Although CD8+ lymphocytes in human immunodeficiency virus type 1 (HIV-1)-infected
individuals have been demonstrated to suppress viral replication, the mechanisms of inhibition …
individuals have been demonstrated to suppress viral replication, the mechanisms of inhibition …
β-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans
CD8 + lymphocytes are believed to be important in host defence against the human
immunodeficiency virus (HIV)-1, inhibiting HIV-1 replication through both cytolytic and non-cytolytic …
immunodeficiency virus (HIV)-1, inhibiting HIV-1 replication through both cytolytic and non-cytolytic …
Biomimetic enzyme nanocomplexes and their use as antidotes and preventive measures for alcohol intoxication
Organisms have sophisticated subcellular compartments containing enzymes that function
in tandem. These confined compartments ensure effective chemical transformation and …
in tandem. These confined compartments ensure effective chemical transformation and …
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
Background Baricitinib and dexamethasone have randomised trials supporting their use for
the treatment of patients with COVID-19. We assessed the combination of baricitinib plus …
the treatment of patients with COVID-19. We assessed the combination of baricitinib plus …
Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression
…, TC Friedrich, JD Lifson, OO Yang… - The Journal of …, 2007 - journals.aai.org
CD8+ T cells are a key focus of vaccine development efforts for HIV. However, there is no
clear consensus as to which of the nine HIV proteins should be used for vaccination. The early …
clear consensus as to which of the nine HIV proteins should be used for vaccination. The early …
Gene therapy for adenosine deaminase–deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans
…, X Wang, D Gjertson, OO Yang… - … , The Journal of the …, 2012 - ashpublications.org
We conducted a gene therapy trial in 10 patients with adenosine deaminase (ADA)–deficient
severe combined immunodeficiency using 2 slightly different retroviral vectors for the …
severe combined immunodeficiency using 2 slightly different retroviral vectors for the …